Thermo Fisher推出DXR3 SmartRaman+,实现无损在线拉曼质量控制——研发世界
Thermo Fisher adds DXR3 SmartRaman+ for non-destructive, at-line Raman QC - R&D World
生物技术与制药领域的最新动态
Thermo Fisher adds DXR3 SmartRaman+ for non-destructive, at-line Raman QC - R&D World
High school class spends a day at Agilent Technologies - Coastal View News
Octane Medical Group Signs Agreement to Acquire Lonza's Personalized Medicine Business - TMX Newsfile
Waters Corporation Stock Review 2026: Growth and Profitability Concerns - News and Statistics - IndexBox
Thermo Fisher introduces chromogenic culture media for faster identification of Candida infections - R&D World
10x Genomics (TXG) CEO sells shares and makes stock gift - Stock Titan
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'
Pfizer's oncology R&D strategy: Jeff Legos on speed, breadth and novel combinations
Alternative splicing strategy shows promise for Rett syndrome
Yale’s Craig Crews builds model to guide biotech startups out of academia’s ‘valley of death’
FDA's top operating official Butler to retire, deputy to take over in April
Roche announces $481m investment in South Korean biotech sector - Investment Monitor
Moderna to pay up to $2.25B to end mRNA vaccine patent fight
Financings for March 4, 2026
In the clinic for March 4, 2026
Other news to note for March 4, 2026
Regulatory actions for March 4, 2026
Sanofi licenses Sino Biopharm’s JAK/ROCK drug for $1.4B
China approves first noninvasive therapy for cervical precancer
Blackstone puts $400M into Teva, Sanofi gut disease drug